The U.S. Food and Drug Administration has approved a new non-hormonal treatment to help women manage menopause symptoms such as hot flashes and night sweats. Elinzanetant (Lynkuet), a once-daily pill, is expected to be available within weeks. These uncomfortable symptoms affect up to 80% of women during menopause and can last a decade or more, significantly affecting quality of life and sleep, The Menopause Society states. For women seeking treatment who cannot safely take hormone therapy or